Veriheal

NOVEMBER 4, 2021

In 2018, a rule limiting MMJ doctors in the state to 100 patients or less was eliminated , expanding the availability of MMJ for state residents. Edwards signed a bill in June allowing medical patients access to cannabis flower rather than just concentrates, which will go into effect in January 2022. Starting Aug.

Law 102

Law Decriminalization Advocacy Programs 102

Cannabis Law Report

JUNE 19, 2022

The Multi-organization psychedelic partnership is set to launch on June 23 2022. The Psychedelic Access and Research European Alliance (PAREA) is a group founded in 2022 and comprised of 15 organizations with common goals in the field of mental health and psychedelics. — Pain Alliance Europe (@pain_europe) June 10, 2022.

Therapy 52

Therapy Advocacy Events Treatment 52

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. MAPS PBC strives to establish a supportive, equitable and accessible work environment.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

DECEMBER 5, 2021

ONE year on from the formal recognition of the potential for cannabis as a medicine almost 200 global advocacy and civil society groups are backing for calls for greater transparency over emerging new cannabis guidelines. The convened 133rd meeting of the INCB in February 2022, should be a transparent process and informed by civil society.

Research and Development 118

Research and Development Medicine Access Advocacy 118

Cannabis Law Report

JANUARY 21, 2022

Founding member of the National Cannabis Industry Association, Lifetime Investor member of the ArcView Group, and sustaining member of Students for Sensible Drug Policy (SSDP) and Americans for Safe Access (ASA). Looking forward to shaping cannabis policy and growing the market internationally.

Research and Development 52

Research and Development Education Advocacy Policy 52

Cannabis Law Report

FEBRUARY 16, 2022

February 15, 2022. While I’m proud of so much of the work we have done to increase access to cannabis for tens of millions of people across the country, in hindsight, it’s clear that Parallel has not handled the social responsibility that came with being in such a privileged position in the markets we serve. Announcements.

Policy 52

Policy Advocacy Legislation Business 52

Cannabis Law Report

SEPTEMBER 1, 2021

in Spring 2022. Veriheal was founded by Adetunji and Green in 2017 with a mission to become the go-to online destination for prospective medical cannabis patients looking to obtain a medical marijuana (MMJ) card and access educational resources.

Patients 104

Patients Cannabis Education Extraction 104

Cannabis Law Report

NOVEMBER 29, 2021

Since Trulieve was founded, our patients, customers and employees have been at the heart of everything we do. Established ESG targets for 2022 with key activities of reducing our carbon footprint, broadening our Diversity, Equity, and Inclusion (DEI) activities, and establishing a board committee.

Topical 52

Topical Business Cannabis Access 52

Cannabis Law Report

MAY 18, 2022

The study was completed on March 22, 2022, and involved 1,061 participants, providing a 98% power rating on its results, which is statistically significant. Hemp Roundtable, the hemp industry’s national advocacy organization. “The This is a significant step for patients and consumers,” stated Tiffany Devitt, CannaCraft, Inc.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

JULY 18, 2019

All of our state MMTC FL licensed clinics and dispensaries incorporate the lofty goals of both patient and product availability ( access ) and affordability ( cost ). . Whether or not these common goals of access and affordability are always achievable for MMTC physician clinics and their dispensary counterparts remains undecided.

Marijuana 40

Marijuana Dispensary Research and Development Patients 40

Veriheal

JUNE 21, 2023

There will also be measures put in place to control therapeutic access to psilocybin while awaiting federal reform. If approved by the Food and Drug Administration (FDA), this psychedelic would be used to treat chronic and life-threatening mental disorders, especially for patients with limited access to effective treatments.

Access 97

Access Legalization Research and Development Legislation 97

Cannabis Law Report

MAY 18, 2022

The study was completed on March 22, 2022, and involved 1,061 participants, providing a 98% power rating on its results, which is statistically significant. Hemp Roundtable, the hemp industry’s national advocacy organization. “The This is a significant step for patients and consumers,” stated Tiffany Devitt, CannaCraft, Inc.

Safety 52

Safety Hemp Research and Development Data 52

SpeedWeed

SEPTEMBER 14, 2021

An advocacy group took a crucial procedural step on Wednesday toward eventually getting a pair of medical marijuana proposals before Nebraska voters on next year’s ballot. We’ve received so much encouragement from individuals all across the state, who support the many patients like our son Colton, who desperately need access to this medicine.

Marijuana 63

Marijuana Legislation Advocacy Epilepsy 63

The Cannigma

DECEMBER 12, 2022

Turning down activity in the DMN allows better access to new areas of the brain, which can boost creativity and improve problem solving. Using integration or psychotherapy along with these medicines allows patients to incorporate the positive effects permanently. The after-glow is essentially the opposite of a hangover.

History 119

History Microdosing Research and Development Clinical Trials 119

Veriheal

AUGUST 31, 2021

His device not only provides an accessible option for cannabis users who are moving away from smoking but also opens up the opportunity for unique experiences with cannabis in the same way Starbucks revolutionized how people drink coffee. . Essay Summary: Camille is a registered nurse working towards a career as a Family Nurse Practitioner.

Research and Development 116

Research and Development Supply Chain Programs Education 116

Cannabis Law Report

FEBRUARY 28, 2022

Bronner’s, family-owned maker of the top-selling natural brand of soap in North America, has expanded its mental healthcare benefits to include Ketamine Assisted Therapy, as a first step in providing access to Psychedelic Assisted Therapy to employees to promote mental health. Coverage for Dr. Bronner’s employees began on January 1, 2022.

Therapy 52

Therapy Treatment Research and Development Advocacy 52

The Cannigma

FEBRUARY 16, 2022

So, with that, we should get into it, but don’t forget to check out our segment with Americans for Safe Access. We always have a nice little tidbit when we’re all about advocacy and access to cannabis for all. billion made in two years, just two years from January 2020 to January 2022. How are you?

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

Veriheal

FEBRUARY 4, 2022

The state’s leading physician advocacy group, the Vermont Medical Society , initially issued the rejected recommendations to the Cannabis Control Board. However, qualifying patients were forced to wait until 2013 to access the state’s licensed dispensaries for their medicine.

THC 96

THC Decriminalization Cannabis Concentrates 96

SpeedWeed

MARCH 2, 2021

The legislature’s priorities include finding a way to subsidize medical cannabis for low-income patients, providing state grants for minority communities most affected by prohibition, and wiping out previous low-level marijuana convictions. ounces of marijuana, with retail sales starting in 2022. Connecticut marijuana laws.

Legalization 52

Legalization Recreational Legislation Cannabis 52

SpeedWeed

SEPTEMBER 14, 2021

The advocacy group released a statement on the recall election that said Newsom has been criticized for not pushing hard enough to reduce some of the industry’s burdens and for being a “stickler” for anti-smoking rules that wrongfully treat cannabis like tobacco. Newsom has pushed for that deadline to be extended another six months.

Cultivation 82

Cultivation Supply Chain Cannabis Business 82

SpeedWeed

SEPTEMBER 13, 2021

The advocacy group released a statement on the recall election that said Newsom has been criticized for not pushing hard enough to reduce some of the industry’s burdens and for being a “stickler” for anti-smoking rules that wrongfully treat cannabis like tobacco. Newsom has pushed for that deadline to be extended another six months.

Education 77

Education Supply Chain Cannabis Business 77

SpeedWeed

SEPTEMBER 13, 2021

The advocacy group released a statement on the recall election that said Newsom has been criticized for not pushing hard enough to reduce some of the industry’s burdens and for being a “stickler” for anti-smoking rules that wrongfully treat cannabis like tobacco. Newsom has pushed for that deadline to be extended another six months.

Supply Chain 76

Supply Chain Business Advocacy Legislation 76

SpeedWeed

SEPTEMBER 11, 2021

The advocacy group released a statement on the recall election that said Newsom has been criticized for not pushing hard enough to reduce some of the industry’s burdens and for being a “stickler” for anti-smoking rules that wrongfully treat cannabis like tobacco. Newsom has pushed for that deadline to be extended another six months.

Law 52

Law Supply Chain Cannabis Business 52

SpeedWeed

SEPTEMBER 10, 2021

The advocacy group released a statement on the recall election that said Newsom has been criticized for not pushing hard enough to reduce some of the industry’s burdens and for being a “stickler” for anti-smoking rules that wrongfully treat cannabis like tobacco. Newsom has pushed for that deadline to be extended another six months.

Supply Chain 52

Supply Chain Cannabis Business Advocacy 52